Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Does Venetoclax Cause Vitiligo?

Sujatha Baddam, MD, Jorge Diaz Castro, MD

Blood (2019) 134 (Supplement_1): 5139.

https://doi.org/10.1182/blood-2019-130854

Published: 2019

Journal Articles

Erythrocyte Deformability As a Potential Biomarker for Chronic Fatigue Syndrome

Amit K Saha, Brendan R Schmidt, BS, Julie Wilhelmy, BA, Vy Nguyen, Justin Do, Vineeth C Suja, MS, Mohsen Nemat-Gorgani, PhD, Anand K Ramasubramanian, PhD, Ronald W Davis, PhD

Blood (2018) 132 (Supplement 1): 4874.

https://doi.org/10.1182/blood-2018-99-117260

Published: 2018

Journal Articles

Complement-Mediated Thrombotic Microangiopathy: A Murky Presentation of a Rare Disease Entity

Patrick Fleming, MD, Maggie Cheung, MD, David Sokol, MD

Blood (2018) 132 (Supplement 1): 5005.

https://doi.org/10.1182/blood-2018-99-119893

Published: 2018

Journal Articles

Patient Perspectives on Symptom Experience and Impact on Health-Related Quality of Life in Higher-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Low-Blast Acute Myeloid Leukemia

Jill A Bell, PhD, Aaron Galaznik, MD, Farrah A Pompilus, Sara Strzok, Robert J. Fram, MD, Douglas V. Faller, MD PhD, Patrick Marquis

Blood (2017) 130 (Supplement 1): 3458.

https://doi.org/10.1182/blood.V130.Suppl_1.3458.3458

Published: 2017

Journal Articles

Assessment of Standardization and International Scale (IS) Alignment Efforts of BCR-ABL1 Testing By the Chinese CML Alliance in an International External Quality Assessment Program

Ya-Zhen Qin, Stuart Scott, Dao-Xin Ma, Jian-Nong Cen, Cong Han, Min Xiao, MD PhD, Jordan Clark, Peng Zhao, Biao Yin, Annie Tapley, Debbie Travis, Liam Whitby, David Barnett, Xiao-Jun Huang, MD

Blood (2017) 130 (Supplement 1): 2890.

https://doi.org/10.1182/blood.V130.Suppl_1.2890.2890

Published: 2017

Journal Articles

Sample Exchange to Standardize Molecular Monitoring for CML: The EUTOS Experience

Martin C. Müller, MD, Christian Dietz, PhD, Giuseppe Saglio, MD PhD, Francois-Xavier Mahon, MD PhD, Fabrizio Pane, MD, Andreas Hochhaus, MD, Nicholas C.P. Cross, PhD

Blood (2017) 130 (Supplement 1): 2874.

https://doi.org/10.1182/blood.V130.Suppl_1.2874.2874

Published: 2017

Journal Articles

Long-Term Follow up of the Beneficial Effects and of Issues in Subtotal Splenectomy for Hereditary Spherocytosis

Thomas Pincez, Corinne Guitton, Frederic Gauthier, Guenolee Lambert, Veronique Picard, PhDMD, Madeleine feneant Thibault, Narla Mohandas, DSc, Gil Tchernia, MD, Loic Garcon

Blood (2015) 126 (23): 276.

https://doi.org/10.1182/blood.V126.23.276.276

Published: 2015

Journal Articles

Multiple roles of the coagulation protease cascade during virus infection

Silvio Antoniak, Nigel Mackman

Blood (2014) 123 (17): 2605–2613.

https://doi.org/10.1182/blood-2013-09-526277

Published: 2014

Journal Articles

Risk Factors For Bone Pain Among Patients Receiving Myelosuppressive Chemotherapy and Primary Prophylactic Pegfilgrastim

Hairong Xu, M.D., Ph.D., Qi Gong, Florian D Vogl, Esteban Abella, MD, John H Page, MD, ScD

Blood (2013) 122 (21): 1710.

https://doi.org/10.1182/blood.V122.21.1710.1710

Published: 2013

Journal Articles

GeneXpert Essay for BCR-ABL Compared to RT-PCR for Clinical Management of CML

G. Pica, G. Catania, F. Castelli, C Repetto, A. M. Carella, MD, M. Mussap

Blood (2011) 118 (21): 4416.

https://doi.org/10.1182/blood.V118.21.4416.4416

Published: 2011

Journal Articles

High Prevalence of Chronic Fatigue in Long Term Survivors of Childhood Acute Lymphoblastic Leukemia and Lymphoma

Hanne Hamre, Bernward Zeller, Adriani Kanellopoulos, Sophie Dorothea Fosså, Jon Håvar Loge, Ellen Ruud

Blood (2011) 118 (21): 4225.

https://doi.org/10.1182/blood.V118.21.4225.4225

Published: 2011

Journal Articles

Pegylated Interferon a2a (PegIFN) At the Dose of 45μg Per Week in Combination with Imatinib 400mg Is the Recommended Initial Dose for Patients (pts) with Chronic Phase Chronic Myeloid Leukemia (CML-CP): Results From the French SPIRIT Trial of the French CML Group (FI LMC)

Hyacinthe Johnson-Ansah, MD, Joelle Guilhot, Philippe Rousselot, MD, PhD, Rea Delphine, MD, PhD, Francoise Rigal-Huguet, MD, Franck E. Nicolini, MD, PhD, Anne Vekhoff, MD, Agnès Guerci-Bresler, MD, PhD, Michele Schoenwald, MD, Eric Jourdan, Laurence Legros, Valérie Coiteux, MD, Francois-Xavier Mahon, MD, PhD, Claude Preudhomme, Francois Guilhot

Blood (2011) 118 (21): 456.

https://doi.org/10.1182/blood.V118.21.456.456

Published: 2011

Journal Articles

Stability of Conversion Factors for BCR-ABL Monitoring -– Implications for the Frequency of Validation Rounds

Martin C. Müller, MD, Umang Munjal, PhD, Philipp Erben, MD, Thomas Lion, MD, PhD, Gerlinde Mitterbauer-Hohendanner, MD, Hakim El Housni, MD, Nancy Boeckx, Renata Zadro, MD, PhD, Jiri Mayer, MD, PhD, Peter Rohon, MD, Jana Rulcova, PhD, Lykke Grubach, Kadri Raudsepp, MD, Veli Kairisto, MD, PhD, Francois-Xavier Mahon, MD, PhD, Claude Preudhomme, MD, Sandrine Hayette, MD, Jean Gabert, MD, Jean-Michel Cayuela, MD, PhD, Christian Thiede, Lars Galonska, MD, Heike Pfeifer, MD, Carsten Hirt, MD, Philippe Schafhausen, MD, Nils von Neuhoff, PhD, Martin Roskos, MD, Christiane Pott, MD, Thoralf Lange, MD, Georg Hess, MD, Susanne Schnittger, PhD, Annika Dufour, MD, Steffen Koschmieder, MD, Frank Stegelmann, MD, Katerina Zoi, MD, PhD, Kostas Stamatopoulos, Hajnalka Andrikovics, MD, PhD, Tali Tohami, MD, PhD, Giovanni Martinelli, MD, Barbara Izzo, PhD, Enrico Gottardi, MD, Mindaugas Stoskus, Dag Andre Nymoen, MD, Tomasz Sacha, MD, Joana Diamond, MD, PhD, Rodica Talmaci, PhD, Andrey Misyurin, MD, Michael V. Dubina, MD, Tadej Pajic, MD, PhD, Josep F. Nomdedeu, MD, Dolors Colomer, MD, PhD, Gisela Barbany-Bustinza, MD, Hans Ehrencrona, MD, Elisabeth Oppliger Leibundgut, PhD, Jeroen Janssen, MD, Vincent H. J. van der elden, MD, Peter J.M. Valk, MD, PhD, Ugur Ozbek, MD, PhD, Lihui Wang, Gareth Gerrard, PhD, Helen E White, PhD, Thomas Schenk, MD, Thomas Ernst, MD, Rüdiger Hehlmann, MD, Giuseppe Saglio, MD, PhD, Andreas Hochhaus, MD, Nicholas C. P. Cross, PhD

Blood (2010) 116 (21): 893.

https://doi.org/10.1182/blood.V116.21.893.893

Published: 2010

Journal Articles

Kikuchi-Fujimoto Disease In the United States: Clinical and Laboratory Characteristics and Outcomes

Darcie Deaver, MS, ARNP, Mojdeh Naghashpour, MD, PhD, Lubomir Sokol, MD, PhD

Blood (2010) 116 (21): 5100.

https://doi.org/10.1182/blood.V116.21.5100.5100

Published: 2010

Journal Articles

Harmonization of Molecular Monitoring of CML Therapy in Europe – Perspective of Widespread Competence in BCR-ABL Quantification.

Martin C Müller, MD, Nicholas C.P. Cross, Philipp Erben, MD, Thomas Schenk, MD, Thomas Ernst, MD, Rudiger Hehlmann, MD, Susan Branford, PhD, Giuseppe Saglio, Andreas Hochhaus, MD, for the EUTOS Molecular Monitoring Group

Blood (2009) 114 (22): 2616.

https://doi.org/10.1182/blood.V114.22.2616.2616

Published: 2009

Journal Articles

Transfusion Requirements IN RED CELL Disorders.

Prathima Venkatachalam, MBBS, MRCP, Quentin Hill, MBBS, MRCP, FRCPath

Blood (2009) 114 (22): 4193.

https://doi.org/10.1182/blood.V114.22.4193.4193

Published: 2009

Journal Articles

Improving the Efficacy of Non-Radiologic Exclusion of Deep Venous Thrombosis in the Elderly Using the Thrombin Generation Assay

Fred JLM Haas, Roger EG Schutgens, Douwe Biesma, MD, PhD

Blood (2008) 112 (11): 3815.

https://doi.org/10.1182/blood.V112.11.3815.3815

Published: 2008

Journal Articles

Novel player in cell recruitment

Stefanie Dimmeler

Blood (2007) 110 (12): 3821–3822.

https://doi.org/10.1182/blood-2007-09-109355

Published: 2007

Journal Articles

Symptoms and Signs of Hemochromatosis in HFE C282Y Homozygotes Identified by Screening in Primary Care.

Gordon D. McLaren, MD, Christine E. McLaren, Ph.D., Paul C. Adams, M.D., James C. Barton, M.D., David M. Reboussin, Ph.D., Victor R. Gordeuk, M.D., Ronald T. Acton, Ph.D., Emily L. Harris, Ph.D., Mark Speechley, Ph.D., Phyliss Sholinsky, MSPH, Fitzroy W. Dawkins, M.D., Beverly M. Snively, Ph.D., Thomas Vogt, M.D., John H. Eckfeldt, M.D., Ph.D.

Blood (2006) 108 (11): 1545.

https://doi.org/10.1182/blood.V108.11.1545.1545

Published: 2006

Journal Articles

Successful Treatment of Hemolysis and Severe Anemia without Transfusion in a Jehovah’s Witness PNH Patient with the Terminal Complement Inhibitor Eculizumab.

Robert M. Glasser, MD, Christopher F. Mojcik, MD, PhD

Blood (2005) 106 (11): 3768.

https://doi.org/10.1182/blood.V106.11.3768.3768

Published: 2005

NARROW

Does Venetoclax Cause Vitiligo?

Erythrocyte Deformability As a Potential Biomarker for Chronic Fatigue Syndrome

Complement-Mediated Thrombotic Microangiopathy: A Murky Presentation of a Rare Disease Entity

Patient Perspectives on Symptom Experience and Impact on Health-Related Quality of Life in Higher-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Low-Blast Acute Myeloid Leukemia

Assessment of Standardization and International Scale (IS) Alignment Efforts of BCR-ABL1 Testing By the Chinese CML Alliance in an International External Quality Assessment Program

Sample Exchange to Standardize Molecular Monitoring for CML: The EUTOS Experience

Long-Term Follow up of the Beneficial Effects and of Issues in Subtotal Splenectomy for Hereditary Spherocytosis

Multiple roles of the coagulation protease cascade during virus infection

Risk Factors For Bone Pain Among Patients Receiving Myelosuppressive Chemotherapy and Primary Prophylactic Pegfilgrastim

GeneXpert Essay for BCR-ABL Compared to RT-PCR for Clinical Management of CML

High Prevalence of Chronic Fatigue in Long Term Survivors of Childhood Acute Lymphoblastic Leukemia and Lymphoma

Pegylated Interferon a2a (PegIFN) At the Dose of 45μg Per Week in Combination with Imatinib 400mg Is the Recommended Initial Dose for Patients (pts) with Chronic Phase Chronic Myeloid Leukemia (CML-CP): Results From the French SPIRIT Trial of the French CML Group (FI LMC)

Stability of Conversion Factors for BCR-ABL Monitoring -– Implications for the Frequency of Validation Rounds

Kikuchi-Fujimoto Disease In the United States: Clinical and Laboratory Characteristics and Outcomes

Harmonization of Molecular Monitoring of CML Therapy in Europe – Perspective of Widespread Competence in BCR-ABL Quantification.

Transfusion Requirements IN RED CELL Disorders.

Improving the Efficacy of Non-Radiologic Exclusion of Deep Venous Thrombosis in the Elderly Using the Thrombin Generation Assay

Novel player in cell recruitment

Symptoms and Signs of Hemochromatosis in HFE C282Y Homozygotes Identified by Screening in Primary Care.

Successful Treatment of Hemolysis and Severe Anemia without Transfusion in a Jehovah’s Witness PNH Patient with the Terminal Complement Inhibitor Eculizumab.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only